US Patent Issued to HANGZHOU CONVERD on June 17 for "Therapeutic agents comprising nucleic acids and CAR-modified immune cells, and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,826, issued on June 17, was assigned to HANGZHOU CONVERD Co. LTD. (Zhejiang, China).

"Therapeutic agents comprising nucleic acids and CAR-modified immune cells, and uses thereof" was invented by Fang Hu (Zhejiang, China), Can Chen (Zhejiang, China), Lin Xiao (Zhejiang, China), Jin Fu (Zhejiang, China), Rong Zhang (Zhejiang, China) and Jinlu Cai (Zhejiang, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are therapeutic agent including nucleic acid and CAR-modified immune cell and the use thereof. The therapeutic agent comprises first composition and second composition, the first composition comprises a nucleic acid having a labeling pol...